Editorial
doi: 10.1056/NEJMe1009141.
Management of immune thrombocytopenia--something old, something new
- PMID: 21067388
- DOI: 10.1056/NEJMe1009141
Item in Clipboard
Editorial
Management of immune thrombocytopenia--something old, something new
N Engl J Med.
.
No abstract available
Comment in
-
Guidelines for immune thrombocytopenia.N Engl J Med. 2011 Feb 10;364(6):580-1; author reply 581. doi: 10.1056/NEJMc1013806. N Engl J Med. 2011. PMID: 21306261 No abstract available.
Comment on
-
Romiplostim or standard of care in patients with immune thrombocytopenia.N Engl J Med. 2010 Nov 11;363(20):1889-99. doi: 10.1056/NEJMoa1002625. N Engl J Med. 2010. PMID: 21067381 Clinical Trial.
Similar articles
-
Plateletpheresis for postsplenectomy rebound thrombocytosis in a patient with chronic immune thrombocytopenic purpura on romiplostim.J Clin Apher. 2013 Aug;28(4):321-4. doi: 10.1002/jca.21254. Epub 2013 Mar 1. J Clin Apher. 2013. PMID: 23450778
-
[Romplostim in the treatment of immune thrombocytopenic purpura at a tertiary hospital].Farm Hosp. 2012 Sep-Oct;36(5):434-7. doi: 10.1016/j.farma.2011.08.006. Epub 2012 Aug 4. Farm Hosp. 2012. PMID: 22871365 Spanish. No abstract available.
-
[New treatment options for primary immune thrombocytopenia].Ugeskr Laeger. 2011 Jan 24;173(4):271-4. Ugeskr Laeger. 2011. PMID: 21262171 Danish.
-
[New therapeutic agents in immunologic idiopathic thrombocytopenic purpura treatment: thrombopoietin receptor agonists].Rev Med Interne. 2009 Oct;30(9 Suppl):13-5. doi: 10.1016/S0248-8663(09)72468-3. Rev Med Interne. 2009. PMID: 19874983 Review. French. No abstract available.
-
[Development of thrombopoietin receptor agonists].Rinsho Ketsueki. 2009 Oct;50(10):1434-43. Rinsho Ketsueki. 2009. PMID: 19915352 Review. Japanese. No abstract available.
Cited by
-
Safety and efficacy of danazol in immune thrombocytopenia: a systematic review.Res Pract Thromb Haemost. 2024 May 17;8(4):102444. doi: 10.1016/j.rpth.2024.102444. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38988949 Free PMC article. Review.
-
Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities.Int J Rheumatol. 2024 Mar 1;2024:6650921. doi: 10.1155/2024/6650921. eCollection 2024. Int J Rheumatol. 2024. PMID: 38464849 Free PMC article. Review.
-
Minimal Residual Disease in Multiple Myeloma: Something Old, Something New.Cancers (Basel). 2021 Aug 27;13(17):4332. doi: 10.3390/cancers13174332. Cancers (Basel). 2021. PMID: 34503142 Free PMC article. Review.
-
Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura.Turk J Haematol. 2021 Aug 25;38(3):181-187. doi: 10.4274/tjh.galenos.2021.2021.0216. Epub 2021 Jun 24. Turk J Haematol. 2021. PMID: 34162173 Free PMC article.
-
Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review.Can J Kidney Health Dis. 2021 Apr 22;8:20543581211008707. doi: 10.1177/20543581211008707. eCollection 2021. Can J Kidney Health Dis. 2021. PMID: 33996107 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
